XTL Biopharmaceuticals Ltd. (XTLB)

XTL Biopharmaceuticals Statistics

Total Valuation

XTLB has a market cap or net worth of $14.00 million. The enterprise value is $12.00 million.

Market Cap	14.00M
Enterprise Value	12.00M

Important Dates

The next estimated earnings date is Tuesday, August 20, 2024, before market open.

Earnings Date	Aug 20, 2024
Ex-Dividend Date	n/a

Share Statistics

XTLB has 5.45 million shares outstanding.

Shares Outstanding	5.45M
Owned by Insiders (%)	12.20%
Owned by Institutions (%)	4.92%
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	6.31
P/FCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -57.30% and return on invested capital (ROIC) is -34.46%.

Return on Equity (ROE)	-57.30%
Return on Assets (ROA)	-53.90%
Return on Capital (ROIC)	-34.46%
Revenue Per Employee	n/a
Profits Per Employee	-$254,571
Employee Count	7
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +147.10% in the last 52 weeks. The beta is 0.94, so XTLB's price volatility has been similar to the market average.

Beta (5Y)	0.94
52-Week Price Change	+147.10%
50-Day Moving Average	2.45
200-Day Moving Average	1.61
Relative Strength Index (RSI)	55.52
Average Volume (20 Days)	9,984

Short Selling Information

Short Interest	17,727
Short Previous Month	9,872
Short % of Shares Out	1.02%
Short % of Float	n/a
Short Ratio (days to cover)	0.72

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-765,000
Pretax Income	-1.78M
Net Income	-1.78M
EBITDA	-1.78M
EBIT	-1.78M
Earnings Per Share (EPS)	-$0.30

Balance Sheet

The company has $2.01 million in cash and no debt, giving a net cash position of $2.01 million or $0.37 per share.

Cash & Cash Equivalents	2.01M
Total Debt	n/a
Net Cash	2.01M
Net Cash Per Share	$0.37
Equity (Book Value)	2.22M
Book Value Per Share	0.41
Working Capital	n/a

Cash Flow

Operating Cash Flow	-707,000
Capital Expenditures	n/a
Free Cash Flow	-707,000
FCF Per Share	-$0.13

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

XTLB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.00%
Shareholder Yield	0.00%
Earnings Yield	-12.73%
FCF Yield	-5.05%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on February 10, 2017. It was a reverse split with a ratio of 1:5.

Last Split Date	Feb 10, 2017
Split Type	Reverse
Split Ratio	1:5

Scores

Altman Z-Score	n/a
Piotroski F-Score	1